This will allow patients using any of the implant makers to benefit from PNV's breast device, which will likely be superior and cost less than the biological devices currently available. The big players in the US are Allergan (AbbVie), Mentor and Sientra. Establishment Labs is still in clinical trials. Huge market, on both the reconstructive and cosmetic side. Very positive development.
Ann: PNV brings Breast Device in-house, page-21
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.38 |
Change
0.060(2.59%) |
Mkt cap ! $1.643B | |||
| Open | High | Low | Value | Volume |
| $2.35 | $2.39 | $2.33 | $2.357M | 995.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 232 | $2.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.38 | 3934 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |